How much funding has Paratek raised?

Paratek has raised $140.0M in total funding, most recently a convertible note round.

Who are Paratek's investors?

Paratek's investors include Gurnet Point Capital, Novo Holdings, Aisling Capital, The Baupost Group, HBM Healthcare Investments.

Where is Paratek headquartered?

Paratek is headquartered in Philadelphia, Pennsylvania, United States.

What industry is Paratek in?

Paratek operates in Biotech, Healthcare.

Paratek

Acquired

Philadelphia, United States · Founded 1996 · $140.0M raised

Biotech

Healthcare

Headquarters: Philadelphia, Pennsylvania
Employees: 201–500
Founded: 1996
Business Model: B2B

Total Funding: $140.0M
Last Round: $140.0M Convertible NoteApr 2018
Rounds: 1

About

Pharmaceutical company commercializing NUZYRA (omadacycline), an FDA-approved tetracycline-class antibiotic for bacterial infections.

Summary

Paratek is a Biotech company based in Philadelphia, United States, founded in 1996. It has raised $140.0M in total across 1 round, most recently a $140.0M Convertible Note round in Apr 2018. Investors include Gurnet Point Capital, Novo Holdings and Aisling Capital.